Clinical Trial Update: A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the skin irritation potential of tazarotene foam in healthy volunteers, related to acne treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• tazarotene foam (tazarotene)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED